Mengcheng Shen, PhD

Education

• BSc: Nanjing Agricultural University, Nanjing, China (2009)
• MSc: Nanjing Agricultural University, Nanjing, China (2012)
• PhD: University of Alberta, Edmonton, AB, Canada (2018)

Recognition

• Best Poster Award, Stanford Bio-X Interdisciplinary Initiatives Seed Grants Program, 2024
• Best Poster Award, Stanford-Weill Cornell Cardiovascular Research Symposium, 2022
• Peter Pang Best Ph.D. Thesis Award, University of Alberta, 2018
• Med Star Publication Award for Graduate Student, 2018
• Dr. Francis X. Witkowski Publication Award, 2018
• Best Basic Science Podium Research Presentation Award, 2018

Research Interests

leveraging high throughput stem cell- and CRISPR screen-based platforms to study novel genetic variant- and drug-induced cardiovascular pathologies, advancing precision cardiovascular medicine